[Costs and range of health care consumption under general health insurance and sick leaves among patients with inflammatory bowel disease in chosen countries -- a literature review].
Inflammatory bowel disease (IBD) is considered to be common in the developed countries of Europe and in North America. A chronic nature of the disease, bowel and systemic symptoms debilitating daily functioning, coexisting extraintestinal complications, recurrent, not infrequently severe and unpredictable clinical course significantly lower patients' quality of life. When compared with the general population, IBD patients more often take use of health care services. They also experience more episodes of sick leave, which is associated with a greater number of sick leave days per year.
Petryszyn
Paweł
P
Akademia Medyczna, Wrocław, Katedra i Klinika Gastroenterologii i Hepatologii. ppetryszyn@wp.pl
Ziółkowska
Jolanta
J
Paradowski
Leszek
L
D017281:Cost of Illness; D005060:Europe / Q000453:epidemiology; D006264:Health Benefit Plans, Employee / Q000706:statistics & numerical data; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000191:economics* / Q000453:epidemiology* / Q000628:therapy; D007348:Insurance, Health / Q000191:economics / Q000706:statistics & numerical data*; D009656:North America / Q000453:epidemiology; D011788:Quality of Life; D018582:Sick Leave / Q000191:economics / Q000706:statistics & numerical data*